Evommune, Inc. (EVMN) › Cash & EquivalentsEvommune, Inc. (EVMN) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $16.25M2025: $44.06M$44.06M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$44.06M+171.1%2024$16.25M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share